Columbia Laboratories, Inc. (“Columbia” or the “Company”) CBRX announced today that its Board of Directors (the “Board”) has set
a ratio of 1-for-8 for its previously approved reverse stock split of
its common stock, and an anticipated effective date for the reverse
stock split of the later of (i) the filing with the Secretary of the
State of Delaware of a certificate of amendment with respect to the
reverse stock split or (ii) August 9, 2013. The reverse stock split was
approved by the Company's stockholders at its annual meeting of
stockholders on May 1, 2013, where the Company's stockholders granted to
the Board the authority to amend the Company's certificate of
incorporation to effectuate a reverse stock split of its Common Stock at
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in